Jazz Pharmaceuticals
JAZZ
#1410
Rank
C$21.19 B
Marketcap
C$330.19
Share price
-2.62%
Change (1 day)
33.08%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): C$4.82

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$5.21. In 2025 the company made an earnings per share (EPS) of C-$8.30 a decrease over its 2024 EPS that were of C$13.06.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.82-158.06%
2025C-$8.30-163.56%
2024C$13.0639.08%
2023C$9.39-285.03%
2022C-$5.08-34.2%
2021C-$7.71-224.83%
2020C$6.18-53.25%
2019C$13.2223.59%
2018C$10.70-8.24%
2017C$11.6623.74%
2016C$9.4222.12%
2015C$7.71478.49%
2014C$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.53 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
C$11.89 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
C-$1.53-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
C$0.65-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel